Immunicum AB(DE:1YG0)
€0.42+0.00 (+0.24%)
DE:1YG0
Immunicum AB financials statements
€0.42
At close:+0.00 (+0.24%)
Immunicum AB (1YG0) Ratios
1 Followers
Immunicum AB Ratios
DE:1YG0's free cash flow for Q3 2026 was kr-19.19M. For the 2026 fiscal year, DE:1YG0's free cash flow was decreased by kr-343.00K and operating cash flow was kr-18.85M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.70 | 4.29 | 6.44 | 0.79 | 6.72 |
| Quick Ratio | 2.70 | 4.29 | 6.44 | 0.79 | 6.35 |
| Cash Ratio | 2.38 | 3.26 | 4.13 | 0.70 | 5.63 |
| Solvency Ratio | -2.47 | -2.38 | -1.92 | -1.25 | -2.10 |
| Operating Cash Flow Ratio | -3.01 | -2.55 | -5.56 | -1.84 | -5.01 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -3.74 | 0.00 |
| Net Current Asset Value | kr 29.84M | kr 82.77M | kr 137.22M | kr -58.73M | kr 120.99M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.03 | 0.03 | 0.13 | 0.05 |
| Debt-to-Equity Ratio | 0.03 | 0.04 | 0.03 | 0.15 | 0.06 |
| Debt-to-Capital Ratio | 0.03 | 0.03 | 0.03 | 0.13 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.04 | 0.05 |
| Financial Leverage Ratio | 1.07 | 1.08 | 1.07 | 1.21 | 1.10 |
| Debt Service Coverage Ratio | -34.71 | -98.98 | -31.41 | -3.68 | -40.06 |
| Interest Coverage Ratio | -36.63 | -110.87 | -32.31 | -25.40 | -39.62 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.42 | 0.49 | 1.20 | 0.39 | 0.20 |
| Net Debt to EBITDA | 0.40 | 0.66 | 0.98 | -0.28 | 0.92 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 100.00% | -61.87% | -30750.00% |
| EBIT Margin | 0.00% | 0.00% | -355.30% | -4458.13% | -2168766.67% |
| EBITDA Margin | 0.00% | 0.00% | -343.48% | -4296.26% | -2137916.67% |
| Operating Profit Margin | 0.00% | 0.00% | -353.32% | -4463.57% | -2168333.33% |
| Pretax Profit Margin | 0.00% | 0.00% | -356.72% | -4633.89% | -2223500.00% |
| Net Profit Margin | 0.00% | 0.00% | -356.72% | -4573.99% | -2278233.33% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | -356.72% | -4633.89% | -2223500.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 98.71% | 102.46% |
| EBT Per EBIT | 94.18% | 95.01% | 100.96% | 103.82% | 102.54% |
| Return on Assets (ROA) | -18.03% | -18.44% | -13.44% | -22.08% | -18.96% |
| Return on Equity (ROE) | -19.36% | -19.90% | -14.42% | -26.63% | -20.81% |
| Return on Capital Employed (ROCE) | -20.00% | -20.32% | -13.85% | -23.83% | -18.76% |
| Return on Invested Capital (ROIC) | -19.91% | -20.24% | -13.80% | -22.27% | -18.75% |
| Return on Tangible Assets | -118.12% | -78.33% | -45.46% | -155.77% | -72.50% |
| Earnings Yield | -38.75% | -33.85% | -42.07% | -1.31% | -0.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 32.04 | 0.87 | 0.00 |
| Payables Turnover | 0.94 | 0.86 | 0.78 | 0.65 | 0.16 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.18 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.83 | 0.07 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.39 | 0.04 | 0.00 |
| Cash Conversion Cycle | -386.36 | -425.58 | -459.35 | -138.49 | 1198263.25 |
| Days of Sales Outstanding | 0.00 | 0.00 | 11.39 | 419.48 | 1198538.33 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 2014.30 |
| Days of Payables Outstanding | 386.36 | 425.58 | 470.74 | 557.97 | 2289.38 |
| Operating Cycle | 0.00 | 0.00 | 11.39 | 419.48 | 1200552.64 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.56 | -1.64 | -7.05 | -0.51 | -0.69 |
| Free Cash Flow Per Share | -1.57 | -1.68 | -7.13 | -0.56 | -0.70 |
| Dividend Paid and CapEx Coverage Ratio | -265.58 | -43.42 | -89.28 | -9.04 | -101.42 |
| Capital Expenditure Coverage Ratio | -265.58 | -43.42 | -89.28 | -9.04 | -101.42 |
| Operating Cash Flow Coverage Ratio | -4.33 | -3.51 | -6.65 | -1.40 | -3.73 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | -5.71 | -36.50 | -23005.50 |
| Free Cash Flow Yield | -28.00% | -21.49% | -68.13% | -1.16% | -0.81% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.58 | -2.95 | -2.38 | -76.17 | -125.23 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 8.48 | 3484.04 | 2853093.12 |
| Price-to-Book (P/B) Ratio | 0.50 | 0.59 | 0.34 | 20.28 | 26.07 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.57 | -4.65 | -1.47 | -85.93 | -122.81 |
| Price-to-Operating Cash Flow Ratio | -3.58 | -4.76 | -1.48 | -95.44 | -124.02 |
| Price-to-Earnings Growth (PEG) Ratio | 0.14 | 0.07 | -0.00 | 10.36 | 3.19 |
| Enterprise Value Multiple | -2.16 | -2.49 | -1.48 | -81.38 | -132.53 |
| Enterprise Value | 246.47M | 300.16M | 145.28M | 10.47B | 17.00B |
| EV to EBITDA | -2.16 | -2.49 | -1.48 | -81.38 | -132.53 |
| EV to Sales | 0.00 | 0.00 | 5.10 | 3496.16 | 2833370.12 |
| EV to Free Cash Flow | -3.01 | -3.68 | -0.88 | -86.23 | -121.96 |
| EV to Operating Cash Flow | -3.02 | -3.77 | -0.89 | -95.77 | -123.16 |
| Tangible Book Value Per Share | 1.01 | 2.32 | 7.46 | -0.08 | 0.62 |
| Shareholders’ Equity Per Share | 11.21 | 13.26 | 30.51 | 2.38 | 3.29 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.01 | -0.02 |
| Revenue Per Share | 0.00 | 0.00 | 1.23 | 0.01 | 0.00 |
| Net Income Per Share | -2.17 | -2.64 | -4.40 | -0.63 | -0.68 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.99 | 1.02 |
| Interest Burden | 0.94 | 1.01 | 1.00 | 1.04 | 1.03 |
| Research & Development to Revenue | 0.00 | 0.00 | 3.25 | 29.06 | 14299.33 |
| SG&A to Revenue | 0.00 | 0.00 | 1.29 | 16.32 | 7248.33 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.72 | 0.63 | 1.60 | 0.82 | 1.06 |
Currency in SEK
